CSIMarket Company Name, Ticker, Customers, else..
 

Aquabounty Technologies Inc   (NASDAQ: AQB)

Aquabounty Technologies Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

AQB Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Aquabounty Technologies Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, slower than the combined decrease of the AQB's competitors by -24.37 %, recorded in the same quarter.

• List of AQB Competitors





Revenue Growth Comparisons




Net Income Comparison

Aquabounty Technologies Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  AQB Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Aquabounty Technologies Inc




Seastar Medical Holding Corp
Share Performance



-3.56%
Over The Past 5 Days
Seastar Medical Holding Corp
Profile

Seastar Medical Holding Corporation's business model revolves around its operations in the healthcare industry, likely providing medical products or services.

More about Seastar Medical Holding Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 12.171 mill. $ 1.713 mill. $ -13.627 mill.


Kingfish Holding Corporation
Share Performance



0.00%
This Year
Kingfish Holding Corporation
Profile

Kingfish Holding Corporation operates using a specific plan or strategy to generate revenue and conduct business operations.

More about Kingfish Holding Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.004 mill. $ 3.080 mill. $ -0.356 mill.


Zivo Bioscience Inc
Share Performance



-63.71%
This Year
Zivo Bioscience Inc
Profile

Zivo Bioscience Inc's business model is centered around researching, developing, and commercializing naturally derived compounds for various applications in human and animal health. They focus on harnessing the potential of proprietary algal cultures to produce high-value, sustainable bioactive compounds. By leveraging their expertise in algae-based technologies, Zivo Bioscience aims to generate revenue through partnerships, licensing, and commercial agreements in industries such as functional foods, dietary supplements, and pharmaceuticals.

More about Zivo Bioscience Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13.742 mill. $ 0.209 mill. $ -8.486 mill.

Sources: Aquabounty Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Aquabounty Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.